ROS1 and non-small cell lung carcinoma: The ASPYRE-Lung RNA panel consists of 37 common actionable fusion targets relevant to NSCLC including ALK, ROS1, RET, MET exon 14 skipping, and NTRK1, NTRK2 and NTRK3 (Supplementary Table 1).